Loading...
MEDS logo

DataMEDS AI, Inc.NasdaqCM:MEDS Stock Report

Market Cap US$9.0m
Share Price
n/a
1Y-92.5%
7D34.6%
1D1.7%
Portfolio Value
​
View

DataMEDS AI, Inc.

NasdaqCM:MEDS Stock Report

Market Cap: US$9.0m

DataMEDS AI (MEDS) Stock Overview

Operates as a health IT company in the United States. More details

MEDS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Risk Analysis

Negative shareholders equity

Earnings have declined by 100.9% per year over past 5 years

Shareholders have been substantially diluted in the past year

Highly volatile share price over the past 3 months compared to the US market

+ 1 more risk

MEDS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW478,741 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
478,741 investors already sharing narratives
View all narratives

DataMEDS AI, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for DataMEDS AI
Historical stock prices
Current Share PriceUS$3.58
52 Week HighUS$97.50
52 Week LowUS$2.48
Beta0
1 Month Change14.74%
3 Month Change-44.84%
1 Year Change-92.46%
3 Year Changen/a
5 Year Changen/a
Change since IPO-98.12%

Recent News & Updates

Recent updates

Analysis Article • Mar 28

We Think Wellgistics Health (NASDAQ:WGRX) Has A Fair Chunk Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

MEDSUS HealthcareUS Market
7D34.6%0.8%-1.4%
1Y-92.5%35.8%16.4%

Return vs Industry: MEDS underperformed the US Healthcare industry which returned 35.8% over the past year.

Return vs Market: MEDS underperformed the US Market which returned 16.4% over the past year.

Price Volatility

Is MEDS's price volatile compared to industry and market?
MEDS volatility
MEDS Average Weekly Movement37.7%
Healthcare Industry Average Movement7.1%
Market Average Movement7.1%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market3.2%

Stable Share Price: MEDS's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: MEDS's weekly volatility (38%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
202231Prashant Pateldatamedsai.com

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI.

DataMEDS AI, Inc. Fundamentals Summary

How do DataMEDS AI's earnings and revenue compare to its market cap?
MEDS fundamental statistics
Market capUS$8.98m
Earnings (TTM)-US$76.59m
Revenue (TTM)US$14.03m
0.6x
P/S Ratio
-0.1x
P/E Ratio

Is MEDS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MEDS income statement (TTM)
RevenueUS$14.03m
Cost of RevenueUS$20.98m
Gross Profit-US$6.95m
Other ExpensesUS$69.64m
Earnings-US$76.59m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-30.52
Gross Margin-49.51%
Net Profit Margin-545.72%
Debt/Equity Ratio-184.4%

How did MEDS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/23 12:41
End of Day Share Price 2026/07/22 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DataMEDS AI, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.